drugset / Trial / NCT00548119
NeoCart Phase 2 Clinical Trial
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to gather additional information regarding the performance of NeoCart to fill articular cartilage defects in the knee.
Timeline
- Start
- 2006-12
- Primary completion
- 2009-11
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NeoCart | Cell therapy | — | — |